Ouyang Ronghao, Su Xueshang, Liang Yutong, Lu Shunbing, Zhang Ziming, Wei Qingqian, Hu Jintian
From the Department of Cosmetic Injection Center, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Department of Ear Reconstruction, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Plast Reconstr Surg Glob Open. 2025 Aug 5;13(8):e7029. doi: 10.1097/GOX.0000000000007029. eCollection 2025 Aug.
Poly-l-lactic acid (PLLA) has gained popularity as a cosmetic injectable filler due to its excellent biocompatibility and capacity for long-term collagen stimulation. Despite widespread clinical use, a comprehensive evaluation of recent advancements and updated clinical techniques is essential for improving facial rejuvenation outcomes and minimizing complications.
A comprehensive literature review was conducted through databases including PubMed and Web of Science. We analyzed recent advancements, clinical efficacy, safety profiles, injection techniques, and comparative advantages of PLLA relative to other fillers. The review emphasized clinical trial outcomes, practical injection recommendations, and management strategies for common and rare complications.
Recent clinical studies confirmed the effectiveness of PLLA in treating facial wrinkles, volume loss, and enhancing skin elasticity and hydration, with patient satisfaction exceeding 90%. Novel injection techniques such as ultrasound guidance and needle-free microjet injection have improved safety and patient satisfaction. Technological innovations, including particle-size optimization and composite formulations, have further enhanced the biocompatibility, efficacy, and duration of effect of PLLA, significantly reducing adverse events.
PLLA injections offer safe, long-lasting, and natural rejuvenation outcomes for facial and neck areas. Continuous innovation in injection technologies, particle formulations, and combination therapies promises further enhancements. Future research should focus on individualized treatment protocols, optimizing long-term safety and efficacy, and expanding PLLA applications through advanced biomaterials and regenerative approaches.
聚左旋乳酸(PLLA)因其出色的生物相容性和长期刺激胶原蛋白的能力,已成为一种广受欢迎的可注射美容填充剂。尽管临床应用广泛,但对近期进展和更新的临床技术进行全面评估,对于改善面部年轻化效果和减少并发症至关重要。
通过包括PubMed和科学网在内的数据库进行了全面的文献综述。我们分析了PLLA相对于其他填充剂的近期进展、临床疗效、安全性概况、注射技术和比较优势。该综述强调了临床试验结果、实际注射建议以及常见和罕见并发症的管理策略。
近期临床研究证实了PLLA在治疗面部皱纹、容积缺失以及增强皮肤弹性和水合作用方面的有效性,患者满意度超过90%。超声引导和无针微喷射注射等新型注射技术提高了安全性和患者满意度。包括粒径优化和复合配方在内的技术创新进一步增强了PLLA的生物相容性、疗效和作用持续时间,显著减少了不良事件。
PLLA注射为面部和颈部区域提供了安全、持久且自然的年轻化效果。注射技术、颗粒配方和联合疗法的持续创新有望带来进一步的改善。未来的研究应侧重于个性化治疗方案、优化长期安全性和疗效,以及通过先进的生物材料和再生方法扩大PLLA的应用。